Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvectis Pharma, Inc.

8.85
+0.50005.99%
Post-market: 8.850.00000.00%17:59 EDT
Volume:120.74K
Turnover:1.05M
Market Cap:207.01M
PE:-7.97
High:8.99
Open:8.48
Low:8.25
Close:8.35
Loading ...

Nuvectis Pharma to Participate in the 37th Annual Roth Conference

GlobeNewswire
·
14 Mar

Market News Alert: Nuvectis Pharma’s NXP900 Demonstrates Superior Efficacy in NSCLC When Combined with Tagrisso in Cleveland Clinic Study, Following New Buy Recommendation

Business Wire
·
05 Mar

Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC

GlobeNewswire
·
04 Mar

Market News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital Markets

Business Wire
·
27 Feb

Nuvectis Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
26 Feb

Optimistic Buy Rating for Nuvectis Pharma Driven by Promising Oncology Pipeline and Strong Financial Position

TIPRANKS
·
26 Feb

Nuvectis Pharma price target lowered to $11 from $21 at H.C. Wainwright

TIPRANKS
·
26 Feb

Nuvectis Pharma, Inc. : H.c. Wainwright Cuts Target Price to $11 From $21

THOMSON REUTERS
·
26 Feb

Nuvectis Pharma 2024 Net Loss $19M

Benzinga
·
25 Feb

Nuvectis Pharma reports FY24 EPS ($1.11) vs. ($1.43) last year

TIPRANKS
·
25 Feb

Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights

GlobeNewswire
·
25 Feb

Major Investment Alert: Shareholder’s Big Move in Nuvectis Pharma!

TIPRANKS
·
12 Feb

Nuvectis Pharma Closes Stock Offering, Says Underwriter Exercised Overallotment Option

MT Newswires Live
·
07 Feb

Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option

THOMSON REUTERS
·
07 Feb

Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option

GlobeNewswire
·
07 Feb

Nuvectis Pharma Prices $13.5 Million Public Offering of Shares

MT Newswires Live
·
05 Feb